Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novavax, Inc. - Common Stock
(NQ:
NVAX
)
7.780
-0.410 (-5.01%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 15, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Novavax, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
65
66
Next >
Robert F. Kennedy Jr.'s Vaccine Shake-Up Sparks Coast-To-Coast Divide: West Coast Creates Health Alliance, Florida Rolls Back Requirements
↗
September 04, 2025
California, Oregon and Washington form regional vaccine alliance to counter federal guidance under Robert F. Kennedy Jr. as Florida eliminates state mandates.
Via
Benzinga
Florida Chooses 'Medical Freedom' As State Plans To End Vaccine Mandates, Even For Schools: Experts Warn Of 'Major Disaster'
↗
September 04, 2025
Florida plans to end all statewide vaccine mandates, even those required for school attendance, framing the move as a defense of individual liberties, which has since received pushback from public...
Via
Benzinga
Robert Kennedy Jr.'s Leadership Can Only Bring More 'Harm,' Says Top Ex-CDC Official: 'Undoing Of Vaccination' In Works
↗
September 01, 2025
Daskalakis resigned due to political interference in CDC, fears harm will come from new direction. CDC leaders also resign in protest.
Via
Benzinga
Bernie Sanders Demands Health Secretary RFK Jr.'s Resignation As CDC Leadership Crisis Deepens
↗
August 30, 2025
Senator Bernie Sanders called for HHS Secretary RFK Jr.'s resignation over his anti-vaccine policies, ousting of CDC Director Susan Monarez.
Via
Benzinga
Novavax CFO Says Sanofi To Cover Majority Of Future Nuvaxovid Study Costs, Retail Urges Partnership Diversification
↗
August 06, 2025
Via
Stocktwits
Earnings Scheduled For August 6, 2025
↗
August 06, 2025
Via
Benzinga
Novavax Announces Positive Preclinical Data From Bird Flu Vaccine: Retail Wonders When Will The Stock Be Fairly Valued
↗
July 24, 2025
Via
Stocktwits
Elizabeth Warren Slams Trump's CDC Purge: Calls Out RFK Jr's Statements On Measles Vaccines — 'These Fools Can't Be Trusted With Your Health'
↗
August 29, 2025
Sen. Elizabeth Warren (D-Mass.) is sounding the alarm on President Donald Trump's attempts at overhauling leadership at the Centers for Disease Control and Prevention, warning of risks to public...
Via
Benzinga
Topics
Government
RFK Jr. Rescinds Emergency Authorizations For COVID-19 Vaccines
↗
August 27, 2025
FDA approves Pfizer, Moderna, and Novavax Covid vaccines for high-risk groups as emergency authorizations end and vaccines transition to full marketing.
Via
Benzinga
RFK Jr. Makes Good On Promise To End Covid Vaccine Mandate. BioNTech Tumbles.
↗
August 27, 2025
Shares of one vaccine-maker are under pressure on Robert F. Kennedy Jr.'s move on Wednesday.
Via
Investor's Business Daily
Robert Kennedy Jr. Announces End Of FDA Covid Mandates – Clears Moderna, Pfizer, Novavax For High-Risk Groups
↗
August 27, 2025
Moderna’s Covid vaccine has been authorized for individuals six months and older, Pfizer's for ages five and up, and Novavax's for ages 12 and above.
Via
Stocktwits
Trump Administration Plans To Pull COVID-19 Vaccines Off Market 'Within Months'
↗
August 25, 2025
The Trump administration may remove COVID-19 vaccines from the U.S. market as RFK Jr.'s allies gain influence at HHS, with a new vaccine task force led by a known skeptic.
Via
Benzinga
Topics
Government
Novavax Stock Suffers Sharpest Drop In Months After $225M Debt Deal; Retail Still Leans Bullish
↗
August 22, 2025
Bank of America’s downgrade to ‘Underperform’ with a $7 target deepened concerns over Sanofi’s limited commercialization of Nuvaxovid and higher hurdles for future partnerships.
Via
Stocktwits
Novavax Shares Are Trading Higher Thursday: What's Going On?
↗
August 21, 2025
Via
Benzinga
La-Z-Boy Posts Downbeat Q1 Results, Joins James Hardie Industries, Alcon And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
↗
August 20, 2025
Via
Benzinga
CDC Shooting Linked To Suspect's COVID-19 Vaccine Beliefs, Former Staff Blame RFK Jr. Hostility Toward Agency
↗
August 12, 2025
CDC shooting tied to anti-vaccine beliefs sparks warnings from staff, as leaders clash over the future of mRNA vaccines and federal health policy.
Via
Benzinga
FDA May Not Renew Pfizer's Authorization For Covid Shots In Younger Children, Moderna Prepares To Boost Supply
↗
August 11, 2025
Pfizer's COVID-19 vaccine for children under five may lose FDA authorization, leading to potential supply shortages. Modern on board to fill in gaps.
Via
Benzinga
Vinay Prasad's Comeback To FDA Sparks Debate Over Regulatory Direction
↗
August 11, 2025
Vinay Prasad returns as FDA's CBER director after brief exit, raising questions on rare disease drug approvals and mRNA vaccine oversight.
Via
Benzinga
Former Surgeon General Slams RFK Jr. Over mRNA Cuts, Says US 'Conceding To China,' 2 Million Lives At Risk
↗
August 11, 2025
Adams warns cutting funding for mRNA vaccine research will cost lives, derail medical progress, and give China an advantage.
Via
Benzinga
Upcoming Earnings Calls This Week: August 4th - August 10th, 2025
August 07, 2025
This week, from August 4th to August 10th, 2025, marks a busy period in the second-quarter earnings season, with hundreds of companies across various sectors scheduled to report their financial...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Novavax (NVAX) Profit Jumps on Milestone
↗
August 06, 2025
Via
The Motley Fool
Novavax Ups Outlook, Eyes Stronger Nuvaxovid Sales
↗
August 06, 2025
Novavax beats Q2 expectations with $239 million in revenue, lifts 2025 guidance, and reports profit as costs decline and commercial rights shift to Sanofi.
Via
Benzinga
NOVAVAX INC (NASDAQ:NVAX) Surges on Q2 2025 Earnings Beat and FDA Approval for Nuvaxovid
↗
August 06, 2025
Novavax (NVAX) stock surges 5.5% pre-market after Q2 2025 earnings crush estimates with $239M revenue and $0.62 EPS, fueled by Sanofi deal and FDA approval for Nuvaxovid.
Via
Chartmill
Topics
Earnings
RFK Jr. Halts $500 Million In mRNA Vaccine Projects Backed By Pfizer, Moderna: 'We're Prioritizing Safer, Broader Strategies'
↗
August 06, 2025
The Department of Health and Human Services will cancel 22 vaccine development projects totaling $500 million.
Via
Benzinga
Novavax Stock Dips As Moderna's Woes Weigh On Vaccine Sector
↗
August 01, 2025
Shares of Novavax are trading lower Friday morning. The stock appears to be caught in a downdraft affecting COVID-19 vaccine makers after rival Moderna reported disappointing Q2 results.
Via
Benzinga
Novavax Shares Promising Results For Bird Flu Vaccine, Tested In Primates
↗
July 24, 2025
Novavax reports strong immune responses from H5N1 avian flu vaccine candidate, showing promise in single and two-dose preclinical studies.
Via
Benzinga
2 Beaten-Down Stocks That Haven't Hit Rock Bottom Yet
↗
July 11, 2025
Via
The Motley Fool
Topics
Cannabis
FDA Grants Complete Approval To Moderna's COVID-19 Vaccine For Children As Young As 6 Months
↗
July 10, 2025
Moderna's Spikevax receives FDA approval for use in high-risk children; Pfizer, BioNTech appeal U.K. ruling in COVID-19 vaccine patent dispute.
Via
Benzinga
Topics
Intellectual Property
Medical Groups Sue RFK Jr. For Assault On Science Over Unlawful COVID-19 Vaccine Rollbacks
↗
July 08, 2025
Major health groups sue HHS and Robert F. Kennedy Jr. over COVID-19 vaccine policy changes for children and pregnant individuals.
Via
Benzinga
Cooling US Bird Flu Wave Removes Tailwind For Moderna, Novavax, CureVac, Traws Pharma
↗
July 08, 2025
The CDC reportedly deactivated its bird flu emergency response last week, folding surveillance into its regular flu tracking and ending animal infection updates.
Via
Stocktwits
< Previous
1
2
3
4
5
6
7
8
9
...
65
66
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.